Increased CVD Risk in Young Adults With Elevated Non-HDL-C Revisiting the "Ticking Clock" Hypothesis

被引：0
|
作者：
Miller, Michael [1 ]
机构：
[1] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 74卷 / 01期
关键词：
cardiovascular disease prevention; lipids; non-HDL cholesterol; CARDIOVASCULAR-DISEASE; CHOLESTEROL; ATHEROSCLEROSIS; TRIGLYCERIDES; LIPOPROTEIN; ASSOCIATION; MEN;
D O I：
10.1016/j.jacc.2019.04.048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 82
页数：3
相关论文
共 50 条
  • [31] The Clinical Impact of TC/HDL-C Discordance With LDL-C and Non-HDL-C: 20 Year Follow-up of the Atherosclerosis Risk in Communities (ARIC) Study
    Quispe, Renato
    Elshazly, Mohamed B.
    Zhao, Di
    Toth, Peter P.
    Sniderman, Allan D.
    Puri, Rishi
    Virani, Salim S.
    Martin, Seth S.
    Jones, Steven R.
    Michos, Erin D.
    CIRCULATION, 2017, 135
  • [32] Concordance and discordance between apolipoprotein B, LDL-C and Non-HDL-C in statin-treated subjects presenting with chest pain and elevated troponin
    Pitts, R.
    Varghese, V.
    Bhatt, K.
    Parag, J.
    Qian, Z.
    Odeh, W.
    Lee, J.
    Rinehart, S.
    Miller, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 140 - 140
  • [33] Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?
    Enkhmaa, Byambaa
    Prakash, Nishant
    Berglund, Lars
    ATHEROSCLEROSIS, 2018, 274 : 230 - 231
  • [34] Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C
    Pencina, Michael J.
    D'Agostino, Ralph B.
    Zdrojewski, Tomasz
    Williams, Ken
    Thanassoulis, George
    Furberg, Curt D.
    Peterson, Eric D.
    Vasan, Ramachandran S.
    Sniderman, Allan D.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (10) : 1321 - 1327
  • [35] HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes
    Coniglio, R. I.
    Merono, T.
    Montiel, H.
    Malaspina, M. M.
    Salgueiro, A. M.
    Otero, J. C.
    Ferraris, R.
    Schreier, L.
    Brites, F.
    Rosso, L. Gomez
    CLINICAL BIOCHEMISTRY, 2012, 45 (7-8) : 566 - 570
  • [36] ATHEROGENIC LIPOPROTEIN PROFILE AND DECREASED HDL FUNCTION SUPPORT INCREASED RISK OF CARDIOVASCULAR DISEASE (CVD) IN YOUNG WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)
    Hillman, J. K.
    Butts, S. F.
    Playford, M. P.
    Mehta, N. N.
    Dokras, A.
    FERTILITY AND STERILITY, 2013, 100 (03) : S358 - S358
  • [37] Relations of Change in Plasma Levels of LDL-C, Non-HDL-C and apoB With Risk Reduction From Statin Therapy: A Meta-Analysis of Randomized Trials
    Thanassoulis, George
    Williams, Ken
    Ye, Keying
    Brook, Robert
    Couture, Patrick
    Lawler, Patrick R.
    de Graaf, Jacqueline
    Furberg, Curt D.
    Sniderman, Allan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (02): : e000759
  • [38] Predictors of plasma HDL-C concentrations in the Coronary Artery Risk Development in Young Adults (CARDIA) study
    Shikany, James M.
    Bassler, John R.
    Reis, Jared P.
    Schreiner, Pamela J.
    Redden, David T.
    Wilkins, John T.
    Lewis, Cora E.
    JOURNAL OF LIPID RESEARCH, 2025, 66 (01)
  • [39] Increased burden of coronary artery calcium from elevated blood pressure in low-risk young adults
    Kang, Jeonggyu
    Chang, Yoosoo
    Kim, Seolhye
    Sung, Ki-Chul
    Shin, Hocheol
    Ryu, Seungho
    ATHEROSCLEROSIS, 2019, 282 : 188 - 195
  • [40] Ezetimibe/Simvastatin and Atorvastatin Treatment Modify the Correlation of ApoB with LDL-C and Non-HDL-C in Patients with Metabolic Syndrome and Moderately High/High CHD Risk
    Ballantyne, Christie M.
    Grundy, Scott M.
    Hsueh, Willa A.
    Parving, Hans-Henrik
    Robinson, Jennifer G.
    Rosen, Jeffrey B.
    Lin, Jianxin
    Lowe, Robert S.
    Shah, Arvind K.
    Tershakovec, Andrew M.
    DIABETES, 2009, 58 : A180 - A180
12345